Logo

BioVision to Discover Lung Cancer Biomarkers for Abbott

Sep 09, 2005

NEW YORK, Sept. 9 (GenomeWeb News) - BioVision will conduct biomarker discovery research for Abbott, the Hanover, Germany-based company said today.

 

Under the agreement, BioVision will analyze biological samples provided by Abbott to discover lung cancer tumor biomarkers. In return, the company will receive research fees and might obtain milestone and royalty payments, depending on the success of the research.

 

BioVision specializes in the identification of disease-relevant peptides and proteins.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.